Nu Skin Enterprises : Operational Ratios

Nu Skin Enterprises, Inc.

Operational Ratios

Q3 2021 to Q3 2023

	Q2	Q3	Q4		Annual	Q1	Q2	Q3	Q4		Annual	Q1	Q2	Q3
	2021	2021	2021		2021	2022	2022	2022	2022		2022	2023	2023	2023
Return on invested capital	17.5%	17.0%	22.8%		11.4%	11.9%	10.0%	-8.0%	17.6%		8.1%	3.5%	7.7%	-12.5%
Return on equity	25.9%	21.2%	-4.0%		16.1%	16.6%	14.6%	-12.1%	25.5%		11.7%	5.1%	12.0%	-18.0%
Return on asset	11.6%	10.1%	-1.9%		7.7%	8.2%	7.2%	-5.8%	12.6%		5.8%	2.5%	5.7%	-8.2%
Working capital as a % of revenue	12.3%	13.7%	12.7%		12.7%	14.7%	22.2%	19.2%	19.2%		18.0%	20.8%	17.4%	13.4%
Days of inventory supply	204.6	235.2	207.1		213.2	212.6	215.3	169.9	210.8		197.5	246.9	247.2	126.9
Trailing four quarter revenue	2,832,621	2,770,426	2,695,669		2,695,669	2,623,542	2,480,102	2,376,755	2,225,659		2,225,659	2,102,222	2,041,864	2,002,831
Average four quarter revenue growth	23.3%	16.3%	6.7%			-3.6%	-12.5%	-14.3%	-17.4%			-19.8%	-17.4%	-15.2%
Gross margin	75.6%	75.2%	74.2%		75.0%	73.3%	73.6%	67.7%	71.7%		71.7%	72.3%	72.9%	58.6%
Selling expense (%)	39.9%	40.6%	39.1%		40.1%	40.1%	39.1%	40.3%	38.5%		39.5%	39.1%	37.0%	37.6%
G&A (%)	23.6%	24.4%	24.4%		24.3%	24.6%	25.3%	25.7%	24.4%		25.0%	27.8%	27.4%	26.2%
Operating margin	12.1%	10.2%	3.0%		8.7%	8.6%	9.2%	-3.8%	5.3%		5.0%	3.3%	8.5%	-5.3%
Net income margin	8.4%	7.8%	-1.4%		5.5%	6.4%	6.1%	-4.7%	11.0%		4.7%	2.4%	5.4%	-7.4%
Trailing four quarters EPS	4.30	4.37	2.85	$	2.86	2.70	2.22	0.74	2.07	$	2.07	1.54	1.41	1.18
EBITDA/Revenue	14.7%	14.2%	5.9%		11.9%	11.6%	11.5%	-1.3%	9.1%		7.9%	7.6%	12.0%	-1.7%
EBITDAR/Revenue	15.6%	14.7%	6.9%		12.7%	12.3%	11.9%	-0.7%	9.7%		8.4%	8.4%	13.0%	-1.0%